Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruhisa Inoue

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Communications Biology|October 23, 2021
Induction of inverted morphology in brain organoids by vertical-mixing bioreactorsDang Ngoc Anh Suong, Keiko Imamura, Ikuyo Inoue, et al.
Communications Medicine|November 28, 2023
AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cellsYuki Yoshioka, Juliana Bosso Taniguchi, Hidenori Homma, et al.
Nippon Ganka Gakkai Zasshi|May 22, 2009
[Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)]Noriyasu Hashida, Shigeo Ito, Toshihide Hasegawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease modelsHaruhisa Inoue, Ling Lin, Xinhua Lee, et al.
Stem Cell Research|October 17, 2017
Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutationNagahisa Murakami, Taizo Ishikawa, Takayuki Kondo, et al.
European Journal of Cell Biology|March 30, 2025
iPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-TauKeiko Imamura, Ayako Nagahashi, Aya Okusa, et al.
Plos One|October 11, 2011
Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's diseaseNaoki Yahata, Masashi Asai, Shiho Kitaoka, et al.
Physiological Reviews|October 18, 2018
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and DevelopmentPeter Karagiannis, Kazutoshi Takahashi, Megumu Saito, et al.
Stem Cell Reports|March 25, 2015
Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCsMichiko Yoshida, Shiho Kitaoka, Naohiro Egawa, et al.
Plos One|June 24, 2011
P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gatingHiroki Takeuchi, Michiyo Iba, Haruhisa Inoue, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Communications Biology|October 23, 2021
Induction of inverted morphology in brain organoids by vertical-mixing bioreactorsDang Ngoc Anh Suong, Keiko Imamura, Ikuyo Inoue, et al.
Communications Medicine|November 28, 2023
AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cellsYuki Yoshioka, Juliana Bosso Taniguchi, Hidenori Homma, et al.
Nippon Ganka Gakkai Zasshi|May 22, 2009
[Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)]Noriyasu Hashida, Shigeo Ito, Toshihide Hasegawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease modelsHaruhisa Inoue, Ling Lin, Xinhua Lee, et al.
Stem Cell Research|October 17, 2017
Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutationNagahisa Murakami, Taizo Ishikawa, Takayuki Kondo, et al.
European Journal of Cell Biology|March 30, 2025
iPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-TauKeiko Imamura, Ayako Nagahashi, Aya Okusa, et al.
Plos One|October 11, 2011
Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's diseaseNaoki Yahata, Masashi Asai, Shiho Kitaoka, et al.
Physiological Reviews|October 18, 2018
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and DevelopmentPeter Karagiannis, Kazutoshi Takahashi, Megumu Saito, et al.
Stem Cell Reports|March 25, 2015
Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCsMichiko Yoshida, Shiho Kitaoka, Naohiro Egawa, et al.
Plos One|June 24, 2011
P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gatingHiroki Takeuchi, Michiyo Iba, Haruhisa Inoue, et al.
Pageof 14